memantine transdermal (MRX-7MLL)
/ MEDRx
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 05, 2026
A Phase 1 Open-label Skin Safety, Tolerability and Pharmacokinetic Study of MRX-7MLL (Memantine Transdermal Delivery System) in Healthy Adults
(ANZCTR)
- P1 | N=16 | Completed | Sponsor: MedRx Australia Pty Ltd | Not yet recruiting ➔ Completed
Trial completion • Alzheimer's Disease • CNS Disorders • Dementia
1 to 1
Of
1
Go to page
1